Members in the News

Scientific Director of Intramural Research, Dr. John O’Shea, Elected to the U.S. National Academy of Sciences

Scientific Director of Intramural Research, Dr. John O’Shea, Elected to the U.S. National Academy of Sciences On May 2, 2023, NIAMS Scientific Director of Intramural Research, Dr. John O’Shea, was elected to the U.S. National Academy of Sciences at the conclusion of the Academy’s 160th annual meeting. This designation – considered one of the [READ MORE]

Members in the News

Brendan Jenkins to join the University of Adelaide South Australian Immunogenomics Cancer Institute (SAiGENCI) as Program Leader in Tumour Inflammation and Immunotherapy

Professor Brendan Jenkins, Program Leader in Tumour Inflammation and Immunotherapy, SAiGENCI After 18 years at the Hudson Institute of Medical Research in Melbourne, Australia, the last 2 years as Centre Head (Centre for Innate Immunity and Infectious Diseases), Professor Brendan Jenkins has accepted a new and exciting position back in [READ MORE]

COVID-19 Special

COVID-19 Special

COVID-19 special: PMID: 36198912 COVID-19 and cellular senescence. Schmitt CA, Tchkonia T, Niedernhofer LJ, Robbins PD, Kirkland JL, Lee S. Nat Rev Immunol. 2022 Oct 5:1-13. doi: 10.1038/s41577-022-00785-2. Online ahead of print.PMID: 36198912 Free PMC article. Review. PMID: 36631691 Innate immune evasion strategies of SARS-CoV-2. Minkoff JM, tenOever B. Nat Rev Microbiol. 2023 [READ MORE]